Guidelines: ESMO Guidelines Compilation (European Union): Difference between revisions
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
Go back to [[European Union]] page | Go back to [[European Union]] page | ||
{{forproviders}} | {{forproviders}} {{forpolicymakers}} | ||
'''Primary purpose:''' Give providers recommendations prepared and reviewed by leading experts in each topic to help patients with the best care available. | '''Primary purpose:''' Give providers recommendations prepared and reviewed by leading experts in each topic to help patients with the best care available. | ||
Revision as of 17:49, 2 July 2024
Go back to European Union page
Primary purpose: Give providers recommendations prepared and reviewed by leading experts in each topic to help patients with the best care available.
Sponsor, manager or home institution: European Society for Medical Oncology.
Type of information: Guidelines for each step in the cancer journey including information on cancer incidence and epidemiology; diagnosis, pathology and molecular biology; staging and risk assessment; management of advanced and metastatic disease; personoalised medicine; long-term implications and survivorship; palliative care; among other information specific to each cancer type. All guidelines have references and methodology sections.
Available Guidelines: ESMO Guidelines.
Cancer Areas of Interest: C00-C97: All cancer types. Click here to learn more.
Access to information: Click here to access.
